Collplant Holdings Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
CLGN
IL0004960188
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | -14.91% | -.--% |
Sales 2024 * | 10.53M 2.83M 1.05B 227M | Sales 2025 * | 53.98M 14.5M 5.4B 1.16B | Capitalization | 251M 67.52M 25.14B 5.41B |
---|---|---|---|---|---|
Net income 2024 * | -60M -16.12M -6B -1.29B | Net income 2025 * | -24M -6.45M -2.4B -516M | EV / Sales 2024 * | 23.9 x |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 4.66 x |
P/E ratio 2024 * |
-4.14
x | P/E ratio 2025 * |
-10.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.27% |
Managers | Title | Age | Since |
---|---|---|---|
Yehiel Tal
CEO | Chief Executive Officer | 71 | 31/12/09 |
Oded Shoseyov
FOU | Founder | 67 | 31/05/04 |
Eran Rotem
DFI | Director of Finance/CFO | 56 | 31/12/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Avri Havron
BRD | Director/Board Member | 76 | 30/04/16 |
Hugh Evans
BRD | Director/Board Member | 58 | 28/03/21 |
Elan Penn
BRD | Director/Board Member | 72 | 31/12/17 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.76% | 909M | |
-19.12% | 129M | |
+6.78% | 60.67M | |
+0.60% | 53.19M |
- Stock Market
- Equities
- CLGN Stock
- CLGN Stock